Journal ArticleOPEN ACCESS

Postbooster antibodies from humans as source of diphtheria antitoxin

Emerging Infectious Diseases (2016) 22(7) 1265-1267
DOI: 10.3201/eid2207.151670
9Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might be useful for treating even severe cases of diphtheria.

Cite

CITATION STYLE

APA

Bermejo-Martin, J. F., Avila-Alonso, A., González-Rivera, M., Tamayo, E., Eiros, J. M., & Almansa, R. (2016). Postbooster antibodies from humans as source of diphtheria antitoxin. Emerging Infectious Diseases, 22(7), 1265–1267. https://doi.org/10.3201/eid2207.151670

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free